Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1911 1
1918 1
1922 1
1923 2
1924 2
1928 2
1929 1
1930 1
1935 1
1937 1
1942 1
1943 2
1945 1
1946 1
1947 1
1949 1
1950 2
1951 1
1952 7
1953 3
1954 2
1955 1
1956 1
1958 1
1959 1
1960 1
1961 8
1962 6
1963 8
1965 5
1966 11
1967 5
1968 11
1969 12
1970 11
1971 7
1972 12
1973 8
1974 7
1975 5
1976 10
1977 10
1978 10
1979 10
1980 12
1981 8
1982 4
1983 11
1984 7
1985 10
1986 9
1987 5
1988 10
1989 12
1990 10
1991 9
1992 13
1993 4
1994 10
1995 13
1996 18
1997 6
1998 8
1999 5
2000 11
2001 8
2002 17
2003 18
2004 22
2005 35
2006 22
2007 28
2008 44
2009 53
2010 46
2011 50
2012 58
2013 61
2014 44
2015 59
2016 65
2017 47
2018 65
2019 67
2020 59
2021 13
Text availability
Article attribute
Article type
Publication date

Search Results

1,169 results
Results by year
Filters applied: . Clear all
Page 1
Understanding type 1 diabetes: etiology and models.
Acharjee S, Ghosh B, Al-Dhubiab BE, Nair AB. Acharjee S, et al. Among authors: ghosh b. Can J Diabetes. 2013 Aug;37(4):269-276. doi: 10.1016/j.jcjd.2013.05.001. Epub 2013 Aug 2. Can J Diabetes. 2013. PMID: 24070892 Review.
Nanocarriers for cancer-targeted drug delivery.
Kumari P, Ghosh B, Biswas S. Kumari P, et al. Among authors: ghosh b. J Drug Target. 2016;24(3):179-91. doi: 10.3109/1061186X.2015.1051049. Epub 2015 Jun 10. J Drug Target. 2016. PMID: 26061298 Review.
Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment.
Dey P, Li J, Zhang J, Chaurasiya S, Strom A, Wang H, Liao WT, Cavallaro F, Denz P, Bernard V, Yen EY, Genovese G, Gulhati P, Liu J, Chakravarti D, Deng P, Zhang T, Carbone F, Chang Q, Ying H, Shang X, Spring DJ, Ghosh B, Putluri N, Maitra A, Wang YA, DePinho RA. Dey P, et al. Among authors: ghosh b. Cancer Discov. 2020 Apr;10(4):608-625. doi: 10.1158/2159-8290.CD-19-0297. Epub 2020 Feb 11. Cancer Discov. 2020. PMID: 32046984 Free PMC article.
Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.
Wyatt RM, Fraser I, Welty N, Lord B, Wennerholm M, Sutton S, Ameriks MK, Dugovic C, Yun S, White A, Nguyen L, Koudriakova T, Tian G, Suarez J, Szewczuk L, Bonnette W, Ahn K, Ghosh B, Flores CM, Connolly PJ, Zhu B, Macielag MJ, Brandt MR, Chevalier K, Zhang SP, Lovenberg T, Bonaventure P. Wyatt RM, et al. Among authors: ghosh b. J Pharmacol Exp Ther. 2020 Mar;372(3):339-353. doi: 10.1124/jpet.119.262139. Epub 2019 Dec 9. J Pharmacol Exp Ther. 2020. PMID: 31818916
Lipoleiomyoma.
Ghosh B, McKeown B, Gumma A. Ghosh B, et al. BMJ Case Rep. 2011 Aug 31;2011:bcr0820114577. doi: 10.1136/bcr.08.2011.4577. BMJ Case Rep. 2011. PMID: 22679054 Free PMC article.
Correspondence.
Arora S, Arora P, Arora R, Ghosh B. Arora S, et al. Among authors: ghosh b. Retina. 2015 Dec;35(12):e77-8. doi: 10.1097/IAE.0000000000000890. Retina. 2015. PMID: 26584442 No abstract available.
1,169 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page